A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights that can help shape strategy for business development, product development and investments.
Key Features:
- Business trends analysis
- In-depth industry overview
- Technology trends analysis
- Forecasts
- Spending, investment, and consumption discussions
- In-depth industry statistics and metrics
- Industry employment numbers
Additional Key Features includes:
- Industry Glossary
- Industry Contacts list, including Professional Societies and Industry Associations
- Profiles of industry-leading companies
- U.S. and Global Firms
- Publicly held, Private and Subsidiaries
- Executive Contacts
- Revenues
- For Public Companies: Detailed Financial Summaries
- Statistical Tables
Key Questions Answered Include:
- How is the industry evolving?
- How is the industry being shaped by new technologies?
- How is demand growing in emerging markets and mature economies?
- What is the size of the market now and in the future?
- What are the financial results of the leading companies?
- What are the names and titles of top executives?
- What are the top companies and what are their revenues?
This feature-rich report covers competitive intelligence, market research and business analysis - everything you need to know about the Biotech, Pharmaceuticals & Genetics Industry.
The Book Provides Unique Analysis of the Following Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry
- The State of the Biotechnology Industry Today
- A Short History of Biotechnology
- Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
- Ethanol Production Soared, But U.S. Federal Subsidy Expired
- Cellulosic Ethanol Makes Slow Commercial Progress
- Major Drug Companies Acquire or Partner With Smaller Biotech Firms
- Pharmaceutical R&D Improves with Artificial Intelligence (AI)
- Nations Compete Fiercely in Biotech Development
- Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
- Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
- Vaccines & Viruses as Therapies/mRNA Shows Great Promise
- Massive R&D Investment Required for Development and Approval of New Drugs/ Drug Prices Soar
- Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
- America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
- Biotech and Orphan Drugs Create New Revenues for Drug Firms
- Revolutionary New Drugs (Zepbound, Ozempic and Wegovy) Treat Obesity, Diabetes and Addiction/Show Promise for Treating Many Other Diseases
- Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
- Market for CBD Remains Steady
- Stem Cells and 3-D Printing - A New Era of Tissue Replacement Takes Shape
- Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
- Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
- Plant-Based Meat Substitutes Developed
- Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
- Immunotherapy, ADCs and CAR-T Create Exciting New Approach to Fighting Cancers
- Technology Discussion - Genes and DNA
- Technology Discussion - Proteins and Proteomics
- Technology Discussion - DNA Chips
- Technology Discussion - SNPs (“Snips”)
- Technology Discussion - Synthetic Biology
- Technology Discussion - Recombinant DNA
- Technology Discussion - Polymerase Chain Reaction (PCR)
The Book Provides In-Depth Tables for the Following Biotech, Pharmaceuticals & Genetics Industry Statistics
- Biotech Industry Statistics and Market Size Overview
- The U.S. Drug Discovery & Approval Process
- U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2023
- Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2023
- Federal R&D & R&D Funding for Basic Research, U.S.: Fiscal Years 2022-2024
- U.S. Exports & Imports of Pharmaceutical Products: 2018-2023
- Prescription Drug Expenditures, U.S.: Selected Years, 2015-2031
- NSF Budget by Appropriation (Dollars in Millions), Fiscal Years: 2023-2025
- Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2022-2024
Table of Contents
Introduction
Chapter 1: Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry
Chapter 2: Biotech, Pharmaceuticals & Genetics Industry Statistics
Chapter 3: Important Biotech, Pharmaceuticals & Genetics Industry Contacts
Chapter 4: THE BIOTECH 350:
Companies Mentioned
- 23andMe Holding Co
- 3SBio Inc
- 4SC AG
- Abbott Laboratories
- AbbVie Inc
- Abeona Therapeutics Inc
- ACELYRIN Inc
- Achieve Life Sciences Inc
- Acorda Therapeutics Inc
- Adaptive Biotechnologies Corporation
- Adcock Ingram Holdings Limited
- Aeterna Zentaris Inc
- Agenus Inc
- Agilent Technologies Inc
- AIM ImmunoTech Inc
- Akebia Therapeutics Inc
- Alcon Inc
- Alimera Sciences Inc
- ALK-Abello A/S
- Alkermes Public Limited Company
- Allergy Therapeutics PLC
- Almirall SA
- Alnylam Pharmaceuticals Inc
- Amarin Corporation plc
- Amgen Inc
- Amicus Therapeutics Inc
- Amneal Pharmaceuticals Inc
- Anika Therapeutics Inc
- Anixa Biosciences Inc
- Aptose Biosciences Inc
- Arcadia Biosciences Inc
- Armata Pharmaceuticals Inc
- Aspira Womens Health Inc
- Assertio Holdings Inc
- Astellas Pharma Inc
- AstraZeneca plc
- Avadel Pharmaceuticals plc
- Avid Bioservices Inc
- BASF SE
- Bausch & Lomb Corp
- Bausch Health Companies Inc
- Baxter International Inc
- Bayer AG
- BGI Genomics Co Ltd
- BioCryst Pharmaceuticals Inc
- Biogen Inc
- BioMarin Pharmaceutical Inc
- Bionano Genomics Inc
- BioNTech SE
- Bio-Rad Laboratories Inc
- Bio-Techne Corporation
- Biotest AG
- Bioventus Inc
- Bristol-Myers Squibb Company
- CareDx Inc
- CASI Pharmaceuticals Inc
- Cassava Sciences Inc
- Cegedim SA
- Celldex Therapeutics Inc
- Cellectis SA
- CEL-SCI Corporation
- Cerus Corporation
- Charles River Laboratories International Inc
- Chemical Works of Gedeon Richter Plc
- Chemomab Therapeutics Ltd
- Chugai Pharmaceutical Co Ltd
- Cibus Inc
- CK Life Sciences Intl (Holdings) Inc
- Cocrystal Pharma Inc
- Collegium Pharmaceutical Inc
- Compugen Ltd
- Comvita Limited
- Corteva Inc (bda Corteva Agriscience)
- CSL Limited
- Cumberland Pharmaceuticals Inc
- Curis Inc
- Cyanotech Corp
- Daiichi Sankyo Company Limited
- DiaSorin SpA
- Divis Laboratories Limited
- Dominari Holdings Inc
- Dr Reddys Laboratories Limited
- Durect Corporation
- Editas Medicine Inc
- Eisai Co Ltd
- Elanco Animal Health Incorporated
- Elementis PLC
- Eli Lilly and Company
- Emergent BioSolutions Inc
- Endo Inc
- Enzo Biochem Inc
- Eurofins Scientific Group SA
- Euro-Med Laboratories Phil Inc
- Evotec SE
- Exelixis Inc
- Faes Farma SA
- Fresh Tracks Therapeutics Inc
- Fufeng Group Co Ltd
- Galapagos NV
- GE HealthCare Technologies Inc
- Genomma Lab Internacional SAB de CV
- Geron Corporation
- Gilead Sciences Inc
- Ginkgo Bioworks Holdings Inc
- GoodRx Holdings Inc
- GSK PLC
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- H Lundbeck A/S
- Halozyme Therapeutics Inc
- Harvard Bioscience Inc
- Hikma Pharmaceuticals PLC
- ICON plc
- IDEXX Laboratories Inc
- Illumina Inc
- ImmuCell Corporation
- Incyte Corporation
- Inotiv Inc
- Inovio Pharmaceuticals Inc
- Insmed Incorporated
- Integra LifeSciences Holdings Corporation
- Integrated BioPharma Inc
- IntelliPharmaCeutics International Inc
- International Flavors & Fragrances Inc
- Interpace Biosciences Inc
- Ionis Pharmaceuticals Inc
- Ipsen SA
- IQVIA Holdings Inc
- Ironwood Pharmaceuticals Inc
- Jazz Pharmaceuticals Public Limited Company
- Johnson & Johnson
- Kangmei Pharmaceutical Co Ltd
- LadRx Corp
- Lexicon Pharmaceuticals Inc
- Lifecore Biomedical Inc
- LifeVantage Corporation
- Ligand Pharmaceuticals Incorporated
- Lineage Cell Therapeutics Inc
- Lonza Group AG
- Mallinckrodt PLC
- Mannatech Incorporated
- Marizyme Inc
- Merck & Co Inc
- Merck KGaA
- Mesoblast Limited
- Microbot Medical Inc
- Moderna Inc
- Myriad Genetics Inc
- Natural Alternatives International Inc
- Navidea Biopharmaceuticals Inc
- Nektar Therapeutics
- NEOGEN Corporation
- NeoGenomics Inc
- Neurocrine Biosciences Inc
- Novartis AG
- Novavax Inc
- Novo Nordisk AS
- Novonesis AS
- Oncotelic Therapeutics Inc
- ONO Pharmaceutical Co Ltd
- OPKO Health Inc
- OraSure Technologies Inc
- Organogenesis Holdings Inc
- Organon & Co
- Orion Oyj
- Otsuka Holdings Co Ltd
- Pacific Biosciences of California Inc
- Pacira BioSciences Inc
- Palatin Technologies Inc
- Perrigo Company plc
- Personalis Inc
- Pfizer Inc
- Precigen Inc
- Prestige Consumer Healthcare
- ProPhase Labs Inc
- PT Tempo Scan Pacific Tbk
- QIAGEN NV
- Quest Diagnostics Incorporated
- Recordati Industria Chimica e Farmaceutica SpA
- Regeneron Pharmaceuticals Inc
- Reliv International Inc
- Repligen Corporation
- RespireRx Pharmaceuticals Inc
- Rigel Pharmaceuticals Inc
- Roche Holding AG
- Rohto Pharmaceutical Co Ltd
- S&W Seed Company
- Samsung BioLogics Co Ltd
- Sangamo Therapeutics Inc
- Sanofi SA
- Sarepta Therapeutics Inc
- Seelos Therapeutics Inc
- Shionogi & Co Ltd
- SIGA Technologies Inc
- Sihuan Pharmaceutical Holdings Group Ltd
- Simcere Pharmaceutical Group Ltd
- Sino Biopharmaceutical Limited
- Sinovac Biotech Ltd
- Soligenix Inc
- Spectral Medical Inc
- Standard BioTools Inc
- Sumitomo Dainippon Pharma Co Ltd
- Sun Pharmaceutical Industries Limited
- Swedish Orphan Biovitrum AB
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Limited
- Thermo Fisher Scientific Inc
- Titan Pharmaceuticals Inc
- Toyobo Co Ltd
- Trinity Biotech plc
- Twist Bioscience Corporation
- UCB SA
- United Laboratories International Holdings Ltd
- United Therapeutics Corporation
- United-Guardian Inc
- Vaxart Inc
- Vericel Corporation
- Vertex Pharmaceuticals Incorporated
- Vetoquinol SA
- Viatris Inc
- Virbac SA
- Windtree Therapeutics Inc
- XOMA Corporation
- Xtant Medical Holdings Inc
- Yield10 Bioscience Inc
- Zimmer Biomet Holdings Inc
- Zoetis Inc
Methodology
The data development evolved from research methods originally established by the founder of the company.
Through the years, a research methodology evolved based on strict guidelines used to build and maintain the content of six proprietary business and industry databases:
- An industry trends database
- An industry statistics database
- Industry Analytics (deep financial data for hundreds of Industry codes)
- A leading companies database
- A business and industry glossary database
- An industry associations and professional societies database
- Analysts are trained to follow research formulas and methodology. They use company-approved sources in their work and post their findings daily to proprietary databases. All research results go through multi-step editing processes. And, all results are date-stamped.
- Internal research, analysis, fact-checking and data gathering by the Research staff.
- Over 3,500 industry associations, professional societies and government agencies worldwide with which the publisher maintains relationships and/or from which they obtain industry-specific/country-specific data.
- Financial analysts, industry executives and industry experts with whom the publisher maintains communications.
- Corporate disclosure documents and financial statements.
- Industry conference proceedings.
- Analysis of white papers, reports, periodicals and publications.
- Multiple proprietaries, government, industry and financial databases developed by the publisher.
LOADING...
